Medpace, Inc. Acquires Symbios Clinical, a US-Based Clinical Research Organization (CRO) Specializing in Medical Device

CINCINNATI, OH, Apr 06 (MARKET WIRE) --
Medpace, a privately held, global, full-service clinical research
organization (CRO) announced that it has acquired Symbios Clinical, a CRO
dedicated to medical device clinical trials with expertise in pre-market,
post-approval and post-market / outcomes trials. Symbios supports the
full spectrum of medical device trials.

This acquisition allows the integration of Medpace's therapeutic
expertise and global reach with the device expertise of Symbios to offer
best-in-class clinical trial management solutions to medical device
companies. Medpace currently offers full service strategic consultation,
Phase I-IV clinical trial management, bio-imaging, central laboratory,
clinical pharmacology, and bioanalytical support for pharmaceutical and
biotechnology companies, which Symbios will be now able to leverage to
complement their service offering for medical device companies as well.

Symbios was founded and is currently led by Chief Executive Officer Ryan
Wilson, BS, MBA, and Managing Partner, Ethan Rooney, BS, MBA. The Symbios
management team brings extensive experience in medical device research.
Ryan Wilson, along with his current management team, will continue to
lead Symbios Clinical as a member of the Medpace group of companies.

"I am pleased to welcome Ryan Wilson and the Symbios team to Medpace as
the head of our medical device business," said Dr. August Troendle,
President and CEO, Medpace. "Ryan and his team have built a successful
company in the growing area of medical device research. They hold a
unique position as a CRO dedicated to conducting medical device trials.
The ability of Medpace to tap into this innovative company for benefit of
our existing and new Sponsors will be valuable as yet another service
area for Medpace, and allow Symbios to benefit from our established
global infrastructure."

Symbios was advised by Fairmount Partners in this transaction. Symbios
Clinical is located in Minneapolis, Minnesota and will continue to
operate out of that area.

ABOUT MEDPACE

Medpace is a leading global full-service clinical research organization
providing Phase I-IV core development services for drug, biologic, and
device programs. With medical and regulatory expertise in multiple
therapeutic specialties, Medpace has assembled the industry's most
experienced and therapeutically focused teams to execute at every level
of the company's operations, providing complete and seamless drug
development services. In June 2009 Medpace was rated as the best CRO by
U.S. Investigators in the 2009 CenterWatch Site Survey.

Medpace creates strategic partnerships with pharmaceutical and
biotechnology companies to provide the most efficient and cost-effective
path to drug development -- from program planning and execution to
product approval.

With 900+ employees and clinical trial experience in over 40 countries,
Medpace has the global reach and capability to conduct studies and
navigate regulatory requirements worldwide. In addition to Phase II-IV
development services, Medpace provides Phase I / IIA clinical services
from Medpace Clinical Pharmacology, central laboratory and
therapeutically specialized testing from Medpace Reference Laboratories,
complete bioanalytical services in all stages of drug development from
Medpace Bioanalytical Laboratories, and central image management and
reading from Imagepace.

Visit the Medpace website at: www.medpace.com

ABOUT SYMBIOS CLINICAL

Symbios Clinical is a CRO for medical devices founded in 2006 in the
Minneapolis, Minnesota area. Symbios offers trial design, site
management, project management, monitoring, and data management for
companies with medical devices in the clinical trial phase. Symbios has
the ability to conduct medical device clinical trials for small or large
sponsors in the US and in Europe. Symbios has therapeutic experience in
multiple device therapies including various cardiovascular and metabolic
diseases.

Visit Symbios Clinical at: www.symbiosclinical.com

Contact:
Mary Kuramoto
+1 513-579-9911 X 2523
m.kuramoto@medpace.com

Copyright 2010, Market Wire, All rights reserved.

-0-